Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
Clinical trial NCT03117361 · TERMINATED
Trial details
- NCT number
- NCT03117361
- Sponsor
- PharmaMar
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2018-07-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.